Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin. transl. oncol. (Print) ; 10(12): 844-846, dic. 2008.
Article in English | IBECS | ID: ibc-123566

ABSTRACT

A woman diagnosed of a renal cell carcinoma in 1989 had a metastatic kidney cancer localised in subcutaneous nodules, gut and lung in 2007. Sorafenib treatment was initiated a 400 mg orally twice a day. The patient developed generalised erythematous skin eruptions and two weeks later a widespread erythematous maculopapular eruption located exclusively on the legs and arms, along with an objective response. The most likely cause of the generalised erythematous skin eruptions was considered to be sorafenib because of the close temporal relationship between exposure to the drug and onset of symptoms. Furthermore, a relationship between sorafenib skin toxicity and treatment efficacy was observed. This therapeutic efficacy of EGFR inhibitors and cutaneous side effects should be better assessed in large cohorts or trials to determine whether the skin toxicity of patients can be linked to an objective antitumour response (AU)


No disponible


Subject(s)
Humans , Female , Middle Aged , Benzenesulfonates/adverse effects , Benzenesulfonates/therapeutic use , Carcinoma, Renal Cell/drug therapy , Dermatitis, Exfoliative/chemically induced , Kidney Neoplasms/drug therapy , Pyridines/adverse effects , Pyridines/therapeutic use , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Dermatitis, Exfoliative/complications , Dermatitis, Exfoliative/diagnosis , Drug Eruptions/complications , Drug Eruptions/diagnosis , Niacinamide/analogs & derivatives , Phenylurea Compounds , Skin , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...